A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit <a rel="external noopener" href="http://pdfs.semanticscholar.org/594c/14a87c65a3e3c4bac7823653e169439f4d0a.pdf">the original URL</a>. The file type is <code>application/pdf</code>.
Evaluation of the Utility of in utero Treatment of Twin Anemia-Polycythemia Sequence
<span title="">2015</span>
<i title="S. Karger AG">
<a target="_blank" rel="noopener" href="https://fatcat.wiki/container/oivgalkkevfxnmns56tyydwrdy" style="color: black;">Fetal Diagnosis and Therapy</a>
</i>
diff >0) = 99.4%], and the neonatal transfusion rate was lower [diff = -30.5% (-60, 0), Pr (diff >0) = 2.6%] in the treated group. Conclusion: In utero treatment for TAPS is associated with a higher resolution rate of TAPS and a longer time between diagnosis and birth, but overall mortality is the same as with expectant management. Abstract Objective: The aim of this study is to evaluate the interest in the in utero treatment of twin anemia-polycythemia sequence (TAPS). Methods: The obstetrical
<span class="external-identifiers">
<a target="_blank" rel="external noopener noreferrer" href="https://doi.org/10.1159/000380822">doi:10.1159/000380822</a>
<a target="_blank" rel="external noopener" href="https://www.ncbi.nlm.nih.gov/pubmed/25790745">pmid:25790745</a>
<a target="_blank" rel="external noopener" href="https://fatcat.wiki/release/42iiq5262zcsdo52dujanugylm">fatcat:42iiq5262zcsdo52dujanugylm</a>
</span>
more »
... and neonatal data on all cases of TAPS followed up in our institution between 2006 and 2013 were reviewed. Statistical analyses were conducted using Bayesian methods. Results: Twenty cases of TAPS were included. Laser therapy or intrauterine transfusion (IUT) was performed on the donor twin in 9 cases. Eleven cases were included in the 'nontreated' group (managed expectantly or diagnosed at birth). The gestational age at diagnosis was lower in the group with treated TAPS [difference (diff) = -22.20 days (-57.13, 14.28), probability (Pr) (diff >0) = 10.6%]. The rate of preterm premature rupture of membranes was higher in the group with treated TAPS [diff = 22.5% (-14, 57), Pr (diff >0) = 89%], but overall mortality was similar. The interval between diagnosis and delivery was longer [diff = 44.37 days (9.41, 77.90), Pr (diff >0) = 99.2%], the TAPS resolution rate was higher [diff = 49.9% (12, 81), Pr
<a target="_blank" rel="noopener" href="https://web.archive.org/web/20190224141915/http://pdfs.semanticscholar.org/594c/14a87c65a3e3c4bac7823653e169439f4d0a.pdf" title="fulltext PDF download" data-goatcounter-click="serp-fulltext" data-goatcounter-title="serp-fulltext">
<button class="ui simple right pointing dropdown compact black labeled icon button serp-button">
<i class="icon ia-icon"></i>
Web Archive
[PDF]
<div class="menu fulltext-thumbnail">
<img src="https://blobs.fatcat.wiki/thumbnail/pdf/59/4c/594c14a87c65a3e3c4bac7823653e169439f4d0a.180px.jpg" alt="fulltext thumbnail" loading="lazy">
</div>
</button>
</a>
<a target="_blank" rel="external noopener noreferrer" href="https://doi.org/10.1159/000380822">
<button class="ui left aligned compact blue labeled icon button serp-button">
<i class="external alternate icon"></i>
Publisher / doi.org
</button>
</a>